| 000 -LEADER |
|---|
| fixed length control field |
04387nam a22004335i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150235.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
111129s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781441999146 |
|
978-1-4419-9914-6 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC261-271 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
614.5999 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
New York, NY : |
| -- |
Springer New York : |
| -- |
Imprint: Springer, |
| -- |
2012. |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wang, Rongfu. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Innate Immune Regulation and Cancer Immunotherapy |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc |
edited by Rongfu Wang. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
X, 478 p. 39 illus., 32 illus. in color. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Introduction -- The role of NKT cells in the immune regulation of neoplastic disease.- γδ T Cells in Cancer -- Toll-like receptors and their regulatory mechanisms -- Cytoplasmic sensing of viral double-stranded RNA and activation of innate immunity by RIG-I-Like Receptors -- Innate immune signaling and negative regulators in cancer -- Dendritic Cell Subsets and Immune Regulation -- Human Dendritic Cells in Cancer -- Regulatory T cells in cancer -- Relationship between Th17 and regulatory T cells in the tumor environment -- Mechanisms and control of regulatory T cells in cancer -- Myeloid Derived Suppressor Cells in Cancer -- Myeloid Derived Suppressor Cells and Treg cells in Tumor Microenvironment -- Cell Surface Co-Signaling Molecules in the Control of Innate and Adaptive Cancer Immunity -- Negative regulators of NF-κB activation and type I interferon pathways -- Role of TGF-β in immune suppression and inflammation -- Indoleamine 2,3-dioxygenase and tumor-induced immune suppression -- Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives -- Human tumor antigens recognized by T cells and their implications for cancer immunotherapy -- Cancer/testis (CT) Antigens: Potential Targets for Immunotherapy -- Tumor antigens and Immune Regulation in Cancer Immunotherapy -- Immunotherapy of Cancer -- Current Progress in Adoptive T-Cell Therapy of Lymphoma -- Adoptive Immunotherapy of Melanoma -- Index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
There has been major growth in understanding innate immune signaling, inflammation, immune suppression and cancer immunotherapy. Innate immune regulation and cancer immunotherapy highlights emerging research about the underlying mechanisms of innate immunity and signaling regulation, inflammation and immune suppression that promote or inhibit cancer development and progression, and offers novel ideas and strategies to develop therapeutic cancer drugs or cell therapy by manipulating or blocking these negative signaling pathways and generating potent antitumor immunity. Recent studies have identified key innate immune receptors or sensors, novel signaling molecules and immune regulatory molecules that control immune responses, inflammation and immune suppression in cancer and other diseases. Major progresses in understanding of tumor antigens, immune suppressive molecules and cell population and novel vaccine strategies bring therapeutic cancer vaccines and drugs in realty. With chapters written by internationally recognized contributors, this book provides essential introduction and guide for immunologists, basic, translational and clinical cancer researchers. Features of this book: Offers the most recent development from basic science to clinical application of cancer immunotherapy, thus serving useful guide for immunologists, and cancer researcher and oncologists. Identify key immune signaling molecules and cell populations that dampen immune responses against cancer, thus providing novel strategies to develop therapeutic cancer vaccines and drugs. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Oncology. |
|
|---|
| Topical term or geographic name as entry element |
Immunology. |
|
|---|
| Topical term or geographic name as entry element |
Toxicology. |
|
|---|
| Topical term or geographic name as entry element |
Biomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Cancer Research. |
|
|---|
| Topical term or geographic name as entry element |
Immunology. |
|
|---|
| Topical term or geographic name as entry element |
Pharmacology/Toxicology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781441999139 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4419-9914-6 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
